InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design (vol 11, pg 1017, 2020)

被引：2
|
作者：
Battelino, Tadej [1 ]
Bosnyak, Zsolt [2 ]
Danne, Thomas [3 ]
Mukherjee, Bhaswati [2 ]
Edelman, Steve [4 ]
Pilorget, Valerie [2 ]
Choudhary, Pratik [5 ,6 ]
Renard, Eric [7 ,8 ,9 ]
Bergenstal, Richard [10 ]
机构：
[1] Univ Ljubljana, Fac Med, Univ Childrens Hosp, UMC, Ljubljana, Slovenia
[2] Sanofi SA, Paris, France
[3] Childrens & Youth Hosp Auf Der Bult, Diabet Ctr Children & Adolescents, Hannover, Germany
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Kings Coll Hosp NHS Fdn Trust, London, England
[6] Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England
[7] Univ Montpellier, Montpellier Univ Hosp, Dept Endocrinol Diabet & Nutr, Montpellier, France
[8] Univ Montpellier, Inst Funct Genom, Montpellier, France
[9] INSERM Clin Invest Ctr, Montpellier, France
[10] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA
来源：
DIABETES THERAPY | 2020年 / 11卷 / 07期
关键词：
D O I：
10.1007/s13300-020-00820-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In the original publication, the timing of baseline CGM assessment was incorrectly stated in the text in two instances; it is correct in Fig. 1.
引用
收藏
页码：1607 / 1608
页数：2
相关论文
共 50 条
  • [1] InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design (vol 11, pg 1017, 2020)
    Battelino, Tadej
    Bosnyak, Zsolt
    Danne, Thomas
    Mukherjee, Bhaswati
    Edelman, Steve
    Pilorget, Valerie
    Choudhary, Pratik
    Renard, Eric
    Bergenstal, Richard
    DIABETES THERAPY, 2020, 11 (08) : 1907 - 1908
  • [2] InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design
    Battelino, Tadej
    Bosnyak, Zsolt
    Danne, Thomas
    Mukherjee, Bhaswati
    Edelman, Steve
    Pilorget, Valerie
    Choudhary, Pratik
    Renard, Eric
    Bergenstal, Richard
    DIABETES THERAPY, 2020, 11 (04) : 1017 - 1027
  • [3] InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
    Tadej Battelino
    Zsolt Bosnyak
    Thomas Danne
    Bhaswati Mukherjee
    Steve Edelman
    Valerie Pilorget
    Pratik Choudhary
    Eric Renard
    Richard Bergenstal
    Diabetes Therapy, 2020, 11 : 1017 - 1027
  • [4] Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
    Tadej Battelino
    Zsolt Bosnyak
    Thomas Danne
    Bhaswati Mukherjee
    Steve Edelman
    Valerie Pilorget
    Pratik Choudhary
    Eric Renard
    Richard Bergenstal
    Diabetes Therapy, 2020, 11 : 1907 - 1908
  • [5] Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
    Tadej Battelino
    Zsolt Bosnyak
    Thomas Danne
    Bhaswati Mukherjee
    Steve Edelman
    Valerie Pilorget
    Pratik Choudhary
    Eric Renard
    Richard Bergenstal
    Diabetes Therapy, 2020, 11 : 1607 - 1608
  • [6] COMPARISON OF SECOND-GENERATION BASAL INSULIN ANALOGUES GLARGINE 300 U/ML AND DEGLUDEC 100 U/ML USING CONTINUOUS GLUCOSE MONITORING IN PEOPLE WITH T1D: INRANGE RANDOMISED CONTROLLED TRIAL
    Battelino, T.
    Danne, T.
    Edelman, S.
    Choudhary, P.
    Renard, E.
    Westerbacka, J.
    Mukherjee, B.
    Picard, P.
    Pilorget, V.
    Bergenstal, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A4 - A4
  • [7] Tertiary CGM endpoints comparing second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in people with type 1 diabetes: inrange randomised controlled trial
    Bergenstal, R.
    Edelman, S.
    Choudhary, P.
    Danne, T.
    Renard, E.
    Westerbacka, J.
    Mukherjee, B.
    Picard, P.
    Pilorget, V.
    Battelino, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S326 - S327
  • [8] Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D-The InRange Randomized Controlled Trial
    Bergenstal, Richard M.
    Edelman, Steven
    Choudhary, Pratik
    Danne, Thomas
    Renard, Eric
    Westerbacka, Jukka
    Mukherjee, Bhaswati
    Picard, Pascaline
    Pilorget, Valerie
    Battelino, Tadej
    DIABETES, 2022, 71
  • [9] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [10] BUDGET IMPACT MODEL FOR INSULIN GLARGINE-300U/ ML (GLA-300) VS INSULIN DEGLUDEC 100 U/ML IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS BASED ON THE INRANGE STUDY
    Safia, M.
    Hachelaf, Z.
    Aissaoui, A.
    Mahieu, A.
    Jabbar, O. A. Abdul
    VALUE IN HEALTH, 2024, 27 (12)
12345